RecruitingNot ApplicableNCT07191314

Long-term Evaluation of a Nasopharyngeal Airway


Sponsor

University of Michigan

Enrollment

20 participants

Start Date

Oct 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This long-term follow-up study will permit continued device use for participants of the parent study (NCT06677151). During study participation the study team will stay in contact with participants as necessary. Additionally, patients will undergo clinical follow-up as needed with their physician(s). At 12 months, participants will complete sleep questionnaires as part of this long-term follow-up period.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Participants who completed the parent study (HUM00179497) and wish to continue using the NPA-OSA device.

Exclusion Criteria1

  • The participants who were non-compliant with the NPA-OSA device during their participation in the parent study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEnasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

The NPA-OSA is a flexible, medical-grade silicone, tube-like device that is self-inserted into the user's nasopharyngeal airway through one nostril prior to sleep and worn throughout the night to reduce or alleviate snoring and obstructive sleep apnea.


Locations(2)

Michigan Medicine

Ann Arbor, Michigan, United States

University of Michigan

Ann Arbor, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07191314


Related Trials